Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor
- PMID: 2153229
- PMCID: PMC249154
- DOI: 10.1128/JVI.64.2.639-641.1990
Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor
Abstract
Reovirus type 3 interfered with the binding of beta-adrenergic antagonist ligands to receptors on Y1 adrenal, C6 glioma, and mouse L cells. This inhibition of beta-adrenergic binding was dose related. Reovirus did not interfere with dopaminergic binding or isoproterenol-induced activation of adenylate cyclase. In addition, reovirus infected Y1 cells, which bind beta-adrenergic antagonist ligands but lack agonist-induced activity. These results suggest that reovirus infection is initiated by binding to antagonist (nonfunctional) domains of the adrenergic receptor complex.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
